Commentary: Aducanumab-Related ARIA: Paean or Lament?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35543641.
- Also identified by DOI 10.1097/RLU.0000000000004252.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Høilund-Carlsen and colleagues raise important issues related to amyloid PET, diagnosis of Alzheimer disease, and recently approved antiamyloid treatment aducanumab. We discuss new developments that may direct us to methods of presymptomatic detection of Alzheimer disease and development of effective prevention and therapy.
Medical subject headings
- Alzheimer Disease